The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A plasma miRNA signature classifier identifies PD-L1 ≥ 50% NSCLC nonresponders to immune checkpoint inhibitors.
 
Claudia Proto
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Roche
Travel, Accommodations, Expenses - Merck Sharp & Dome
 
Arsela Prelaj
No Relationships to Disclose
 
Carla Verri
No Relationships to Disclose
 
Diego Signorelli
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dome
 
Giuseppe Lo Russo
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dome
 
Roberto Ferrara
No Relationships to Disclose
 
Giulia Galli
No Relationships to Disclose
 
Benedetta Trevisan
No Relationships to Disclose
 
Mensah Mavis
No Relationships to Disclose
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Dompè; Ignyta; Incyte; Novartis; Octimet; Pfizer; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Roche
 
Marina Chiara Garassino
Honoraria - AstraZeneca/MedImmune; GlaxoSmithKline; MSD Oncology; MSD Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; Takeda; Tiziana Life Sciences
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; MSD Oncology; Roche; Takeda
Research Funding - AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Gabriella Sozzi
No Relationships to Disclose
 
Mattia Boeri
No Relationships to Disclose